Bluetail Medical Group Emerges as the Standard for Orthobiologic Medicine

Bluetail Medical Group has been practicing Orthopedic Regenerative Medicine since 2004, before the term "Regenerative Orthopedics" was even coined. Initially offering Platelet-Rich-Plasma (PRP), BMG pioneered this field and guided treatment protocols and pathways using early clinical outcomes and anecdotal evidence at a time when very little evidence existed for this emerging field of medicine.

Leading the Way in Regenerative Orthopedics

As one of the original leaders in Orthopedic Regenerative Medicine, BMG continues its dedication to the development of safe and effective regenerative therapies for use in orthopedic conditions. The practice has evolved from offering only PRP therapy to now providing a comprehensive suite of orthobiologic treatments including bone marrow aspirate concentrate (BMAC), prolotherapy, and other advanced regenerative procedures.

BMG's physicians have treated thousands of patients with regenerative therapies, accumulating an extensive body of clinical experience that informs their treatment protocols. This wealth of experience, combined with ongoing participation in clinical research, positions BMG as a leader in setting the standard for orthobiologic medicine.

The practice continues to invest in education, research, and the advancement of regenerative medicine, ensuring that patients receive the most current, evidence-based treatments available.